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Overall, 2%-5% of patients with multiple sclerosis (MS) experienced 
the first e pisode o f d isease b efore t he a ge 1 8 y ears o ld. S ince t he a ge of 
onset among children is not similar to that in general population, clinicians 
often fail to early diagnose the disease. This study aimed to determine the 
epidemiological and clinical patterns of MS among Iranian children. 
Materials & Methods
In this cross-sectional study carried out in Iran in 2014-2015, information 
was collected using a checklist with approved reliability and validity. Method 
sampling was consensus. Data were analyzed using frequency, mean and 
standard deviation indices by means of SPSS ver. 20 software.
Results
Totally, 177 MS children were investigated. 75.7% of them were female. 
Mean (SD), minimum and maximum age of subjects were 15.9 (2), 7 and 18 
yr, respectively. The most reported symptoms were sensory (28.2%), motor 
(29.4%), diplopia (20.3%) and visual (32.8%). Primary MRI results showed 
91.5% and 53.1% periventricular and spinal cord lesions, respectively. 
Conclusion
MS is significantly more common among women. The most common age of 
onset is during the second decades. Visual and motor problems are the most 
symptoms, while, periventricular and spinal cord lesions are the most MRI 
results.
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Introduction 
Multiple Sclerosis (MS) is one of the most common morbidities among young 
adults identifies with central nervous system demyelination (1, 2). It was described 
pathologically for the first time in the 19th century (3). MS is associated with 
inflammation and degeneration of the myelin in CNS in the form of small and large 
single or multiple plaques and can lead to different complications such as reduced 
visual acuity, spastic paralysis and disability, sphincter disorders, impotence 
especially among men, imbalance, speech disorder, seizure, action tremor and 
depression (4, 5).
The main cause of MS is unknown and different etiologic factors have been reported. 
Various genetic, racial, environmental, infectious, toxic, immunologic and allergic 
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by consensus method. After approving by Ethics 
Committee of Shahid Beheshti University of Medical 
Sciences, primary information of patients aged under 
18 yr were collected from relevant clinical centers in 
Tehran (Sian Hospital, Mofid Hospital, Clinic of Dr. 
Sahraian, Clinic of Dr. Moghaddasi), Esfahan (Clinic 
of Dr Ashtari).
Using a checklist including demographic and clinical 
variables such as age, gender, residence area, familial 
history, clinical manifestations at the onset and relapse, 
number of relapses, the time interval between the first 
attack and relapse and MRI results (initial and after 
three months). This checklist was designed based on 
previous similar studies (2-4, 14-16). Content validity 
was assessed according to the expert panels. To evaluate 
the reliability, objective items of the checklist (clinical 
characteristics) were completed for 10 patients and 
repeated after 10 d. The correlation between the answers 
was determined as of 0.79 using Spearman correlation. 
Descriptive statistics such as frequency, mean, standard 
deviation (SD) and median were estimated using SPSS 
software (Chicago, IL, USA).
Results
We recruited 177 MS children most of them were girl 
(75.7%). Mean±SD, minimum and maximum ages 
of them were 15.9±2, 7 and 18 yr, respectively. Of 
them, 35.6% were living in Tehran, 8.5% in Isfahan, 
8.5% in Mazandaran and 32.7% in the other provinces. 
The residence area of the 26 (14.7%) were unknown. 
Moreover, 16.4% had familial history of MS (Table 1).
The most common manifestations at the onset were 
impaired or loss of vision (32.8%), motor (29.4%) 
and sensory (28.2%) disorders. During the relapse, 
31.6%, 30.5%, and 22.6% had sensory problems, motor 
problems and loss of vision, respectively (Table 2). 
Among them, 17.5% reported more than three attacks. 
The time interval between the first attack and relapse 
was more than one year for 52.2% of patients (Table 3). 
Table 4 illustrates the MRI results. 
factors were revealed (6-9). Patients complain of a wide 
spectrum of signs and symptoms from mild to moderate 
and transient to persistent. Many of them show brain 
stem involvement such as vertigo, diplopia, cranial 
nerve paralysis, eye movement disorder, sensory, and 
motor symptoms as the first manifestations. It begins 
as local or sectional myelin degeneration in the central 
nervous system (CNS) among youth follows by irregular 
periods of cure and remission (2, 3, 5).
Periodic neurologic attacks, disability and reduced 
physical, socio-economic and health quality during 
a 30-40 yr period of life is the main characteristics of 
MS (5). According to the disease trend and symptoms, 
it is characterized by relapsing-remitting type (70%), 
primary progressive and secondary progressive types 
(2, 10, 11).
Prevalence of MS among women is four times of that 
among men (2). It normally occurs among young adults. 
Approximately, two-thirds of cases begin between ages 
20-30 yr, most probably in 30-year-old age. However, 
it has been reported even among two-year-old children 
(2, 3, 8, 12). 
According to a longitudinal study conducted in a 
Colombian hospital, 116 MS cases were identified 
before the age of 16 yr. Mean age of onset was 12.73 
yr and the prevalence of early MS was 3.6% (13). 
Maximum and minimum ages of onset were 13 and 
73 yr, respectively in Isfahan (14) and 4 and 13 yr, in 
Tehran (3). 
Since the age of onset among children is not in 
accordance with the common age of the disease, 
clinicians often fail to diagnose the disorder in the early 
stages. In addition, differential diagnosis of MS among 
children is of great importance and may be ignored 
during childhood leading to mental, psychological and 
economical problems for the families. Few relevant 
studies have been carried out. Different studies (2-3, 
14-16) reported heterogenic results making it difficult 
to implement appropriate strategies. This study aimed 
to investigate comprehensively the epidemiological and 
clinical pattern of MS among Iranian children. 
 Materials & Methods
This cross-sectional study was conducted in 2015 
among Iranian children suffering from MS selected 
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Other provinces 60 32.7
Unknown 26 14.7
Family history
First-degree relatives 8 4.5
Second-degree relatives 21 11.9
Total family history 29 16.4
Total 177 100
Table 2. Clinical Characteristics of the Study Population by Symptoms
Symptoms 
At the onset During the relapse
Number (of 177) Percent Number (of 177) Percent
Diplopia 36 20.3 18 10.2
Loss of vision 58 32.8 40 22.6
Color vision disorder 0 - 2 1.1
Scotoma 1 0.6 0 -
Eye movement disorder 1 0.6 3 1.7
Ataxia 28 15.8 40 22.6
Dysarthria 3 1.7 5 2.8
Cranial nerve palsy 7 4 7 4
Sensory 50 28.2 55 31.6
Motor 52 29.4 54 30.5
Behavioral disorder 1 0.6 2 1.1
Seizure 5 2.8 6 3.4
Defecation and urinary problems 2 1.1 10 5.6
Multiple Sclerosis in Children
40 Iran J Child Neurol. SPRING  2017  Vol 11 No 2
Table 3. Number of Attacks and Time between Onset and Relapse
Variables Number Percent
Number of attacks
Single attack 4 2.3
2-3 34 19.2
More than three 31 17.5
No attack 108 61
Total 177 100
Time between onset and 
relapse
Less than 6 months 21 30.4
6-12 months 5 7.2
More than 12 months 36 52.2
Unknown 7 10.1
Total 69 100
Table 4. MRI Results of the Study Population
Results MRI
At the onset After 3 months
Number Percent Number Percent
Number of lesions
<2 12 6.8 42 31.5
>=2 139 78.5 91 68.4
total 151 100 133 100
Periventricular lesion
yes 161 91.5 107 62.2
no 15 8.5 65 37.8
total 176 100 172 100
Juxtacortical lesion
yes 39 22 21 12.2
no 138 78 151 87.8
total 177 100 172 100
 Infrateutorial lesion
yes 20 11.3 22 12.8
no 157 88.7 150 87.2
total 177 100 172 100
Spinal cord involvement
yes 94 53.1 67 39.2
no 83 46.9 104 60.8
total 177 100 171 100
Number of spinal cord 
lesions
<=2 28 34.1 16 26.7
>2 54 65.9 44 73.3
total 82 100 60 100
 Presence of blackhole
yes 1 0.6 1 0.6
no 176 99.4 171 99.4
total 177 100 172 100
Enhancing lesion
yes 29 16.4 23 13.5
no 148 83.6 148 86.6
total 177 100 171 100
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Most of the above studies carried out among patients 
from Capital, Northern and central provinces of Iran. 
Prevalence of MS was reported as 20.1 (95% confidence 
interval: 18.7-22.1) per 100000 population, among 582 
patients. Therefore, Mazandaran- Northern Province 
of Iran- is one of the regions with moderate to high 
prevalence (2). Isfahan (19) and Kermanshah (15) in 
Iran were reported as the high prevalence provinces 
with 35.5 and 43.3 cases per 100000 population, 
respectively (8, 10). The prevalence of MS was reported 
as 73 per 100000 population in the world and 60 per 
100000 population in Iran (16). The prevalence of MS 
in Isfahan was reported as 43.5 per 100000 population 
(20). Although the above reports are in keeping 
with the results of the current study, it requires more 
investigations, because prevalence was not reported 
from all parts of the country. 
Among 20 cases (14 girls and 6 boys) in Mofid Hospital, 
all patients showed increased patellar reflexes. In two-
thirds of them (13 cases), muscle strength had been 
decreased. Impaired cerebellar tests, diplopia, and ataxia 
were observed in half (10 cases), two-thirds (14 cases) 
and two-thirds (13 cases) of MS patients. MRI results 
were abnormal in all cases. Spinal MRI was performed 
for seven patients five of which showed hyper signal 
results in spinal canal. All patients had normal CSF (3).
The epidemiological and clinical characteristics of 
early and late onset MS cases were investigated (155 
patients including 2.6% men and 77.4% females) 
living in Hamadan Province (western province of 
Iran). The first manifestations were optic neuritis in 54 
cases (34.84%), motor disorders in 45 cases (29.04%), 
sensory manifestations in 38 cases (24.51%) and balance 
disorders (cerebellar and brainstem involvement) in 
25 cases (14.83%). Moreover, 25 patients (16.10%) 
showed simultaneously more than two manifestations 
at the onset of disease. Among early onset patients, 
24 cases (14.83%) aged 18 or less, but no clinical or 
epidemiological differences were observed between 
children and adults. In addition, 12.9% of patients had 
familial history of MS (15). 
In Kermanshah (western Iran), among 448 MS cases, 
only five (1.2%) of patients had familial history of 
disease among their first-degree relatives including 
father (one case), sister (three cases) and son (one case). 
Discussion
Iranian women developed MS more than three folds 
greater than Iranian men did and mean age of the 
patients was approximately 16 yr. The most common 
signs and was symptoms during initial and relapse 
phases of disease were visual problems, ataxia and 
sensory-motor dysfunction. More than three attacks 
were observed among 17.5% of patients. More than half 
of them experienced some evidence of relapse at least 
one year after the first attack. Familial history of MS 
was reported by 16.4% of them. MRI results revealed 
that most of patients (78.5%) had at least two lesions and 
37.5% had three or more plaques. While periventricular 
lesions (91.5%) and spinal cord lesions (53.1%) were 
observed among MS patients.
From the viewpoint of gender distribution, the prevalence 
of MS among women in northern part of Iran was 2-4 
folds greater than that among men (2). Corresponding 
figures for women and men were reported as of 70 and 
30 per 100000 population (3), 77.4 and 22.6 per 100000 
population in Hamadan, Iran (15), 65.6 and 21.9 per 
100000 population in Kermanshah, Iran (16)
MS typically occurs among young and middle age 
groups. In two-thirds of cases, it starts during ages 
20 to 40 yr. However, even two-year-old children 
have experienced this disorder (2, 3, 8, 12). Clinical 
presentations are almost similar for children and adults. 
MS remains harmful complications on different aspects 
of children lives. In addition, MRI diagnostic criteria in 
children are similar to those of adults (3, 8, 12). During 
a longitudinal study carried out in a Colombian hospital, 
116 incident cases were reported. The age of onset was 
before 16 for all cases with mean age of 12.73 yr 3.6% 
of them were early onset (17). Prevalence of early MS 
was reported as 19.8% in Jordan (10) and 3.6% in Russia 
(10). A retrospective study among 20 Iranian cases 
reported four and 13 yr as minimum and maximum age 
of onset (3). Since the age of onset among children is 
not in parallel with that among adults, clinicians often 
fail to early diagnose the pediatric MS. Two to five 
percent of cases experienced the first symptoms before 
16 yr (18). The incidence of early MS before 16 has 
been reported as 0.4% to 10.5% globally (17). It can be 
an explanation for the observed disagreement between 
the age patterns and our results.
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